John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 4,846 shares at $3.54 ($17K) on 2022-01-12, disclosed to the SEC on 2022-01-13.
Open-market sale of $17k ADAP by Chief Patient Supply Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 3,770 | $13K | 77.9% |
| 2 | $3.54 | 1,076 | $4K | 22.1% |
| Total | $3.56 avg | 4,846 | $17K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |